echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Celestial Biologics was approved by the CDE to conduct a Phase 3 registered clinical trial of lyzolizumab combined with azacitidine for the treatment of HR-MDS

    Celestial Biologics was approved by the CDE to conduct a Phase 3 registered clinical trial of lyzolizumab combined with azacitidine for the treatment of HR-MDS

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com